Published in Endocr Relat Cancer on March 01, 2008
Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res (2012) 1.55
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol (2009) 1.04
Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1. PPAR Res (2009) 1.01
A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors. Int J Endocrinol (2013) 0.93
Fish oil inhibits human lung carcinoma cell growth by suppressing integrin-linked kinase. Mol Cancer Res (2009) 0.91
Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events. RNA (2014) 0.90
New target genes for the peroxisome proliferator-activated receptor-γ (PPARγ) antitumour activity: Perspectives from the insulin receptor. PPAR Res (2009) 0.76
Morusin suppresses breast cancer cell growth in vitro and in vivo through C/EBPβ and PPARγ mediated lipoapoptosis. J Exp Clin Cancer Res (2015) 0.76
Transcriptional regulation of the HMGA1 gene by octamer-binding proteins Oct-1 and Oct-2. PLoS One (2013) 0.76
Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistance. World J Diabetes (2017) 0.75
MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer (2006) 4.11
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell (1990) 3.98
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene (2007) 3.29
ATF6 as a transcription activator of the endoplasmic reticulum stress element: thapsigargin stress-induced changes and synergistic interactions with NF-Y and YY1. Mol Cell Biol (2000) 2.89
Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science (1995) 2.83
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature (1987) 2.60
The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res (1999) 2.56
Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol (1999) 2.38
Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine. Lancet (1987) 2.30
Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol (1995) 2.22
Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope (1997) 2.15
High level expression of the HMGI (Y) gene during embryonic development. Oncogene (1996) 2.13
Role of the high mobility group A proteins in human lipomas. Carcinogenesis (2001) 2.08
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res (1998) 2.00
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene (1989) 1.94
The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites. J Eur Acad Dermatol Venereol (2009) 1.92
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Oncogene (1994) 1.87
Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues. Br J Cancer (2002) 1.87
Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev (2001) 1.85
The practical use of cytology for diagnosis in dermatology. J Eur Acad Dermatol Venereol (2010) 1.76
Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group. Gastroenterology (1992) 1.72
The RET receptor: function in development and dysfunction in congenital malformation. Trends Genet (2001) 1.67
The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene (1995) 1.61
Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res (1989) 1.61
Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci U S A (2001) 1.60
Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach. Magn Reson Med (1997) 1.60
Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. Oncogene (1997) 1.57
Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene (1998) 1.52
The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene (1990) 1.52
Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths. Radiology (1990) 1.51
Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J (1997) 1.51
Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc Natl Acad Sci U S A (2000) 1.47
Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc Natl Acad Sci U S A (1992) 1.46
Renal artery stenosis detection by combined Gates' technique and captopril test in hypertensive patients. J Nucl Med (1989) 1.41
Occupational asthma caused by styrene. J Occup Med (1984) 1.39
Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene (1996) 1.39
Prostaglandin E2 levels and human periodontal disease. Prostaglandins (1974) 1.38
Acne on an area of post-traumatic neuralgia: an instance of immunocompromised district. J Eur Acad Dermatol Venereol (2010) 1.38
Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res (1996) 1.37
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab (1999) 1.37
Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells. J Clin Invest (1999) 1.30
Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers. Cancer (1994) 1.30
Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res (1998) 1.29
Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol Cell Biol (2001) 1.29
[Borreliosis caused by ticks in Senegal; apropos of 23 cases]. Dakar Med (1983) 1.28
5-Aza-2'-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias. Blood (1984) 1.27
Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res (1985) 1.27
Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y). FASEB J (2001) 1.27
The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer Res (1998) 1.27
Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. Mol Cell Biol (2001) 1.26
Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene (2010) 1.25
Block in the expression of differentiation markers of rat thyroid epithelial cells by transformation with Kirsten murine sarcoma virus. Cancer Res (1982) 1.25
Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. Neuroimage (2005) 1.25
Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1). Mol Cell Biol (2000) 1.24
Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins. Cancer Res (2000) 1.24
Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology (1988) 1.23
Recolonization of the subgingival microflora after scaling and root planing in human periodontitis. J Periodontol (1990) 1.22
Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res (1994) 1.22
An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue. Br J Cancer (2003) 1.20
Thyroid cancer and the Chernobyl accident. Are long-term and long distance side effects of fall-out radiation greater than estimated? J Clin Endocrinol Metab (1997) 1.19
Multiple mechanisms of interference between transformation and differentiation in thyroid cells. Mol Cell Biol (1992) 1.19
RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene (1995) 1.19
Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res (1998) 1.18
RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol (2000) 1.17
The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. Cell Growth Differ (1993) 1.17
The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. J Clin Endocrinol Metab (1998) 1.17
PATZ1 gene has a critical role in the spermatogenesis and testicular tumours. J Pathol (2008) 1.17
Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential. Diabetes Metab Res Rev (2001) 1.17
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. Br J Cancer (2005) 1.17
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol (2007) 1.16
A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor. J Biol Chem (2000) 1.16
PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1. Oncogene (2000) 1.15
High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene (2001) 1.15
Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol (2001) 1.15
Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1994) 1.14
A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern. J Virol (1985) 1.14
Transformation of thyroid epithelium is associated with loss of c-kit receptor. Cancer Res (1995) 1.13
Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker. Cancer Res (1999) 1.11
Why do patients with cerebellar ataxia not use environmental cues for reducing unpredictability of sudden gait stopping? Cerebellum (2013) 1.10
Thymosin beta-10 gene overexpression is a general event in human carcinogenesis. Am J Pathol (1999) 1.10
FRA-1 expression in hyperplastic and neoplastic thyroid diseases. Clin Cancer Res (2000) 1.10
Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology (2005) 1.10
Analysis of bioclimatic time series and their neural network-based classification to characterise drought risk patterns in South Italy. Int J Biometeorol (2006) 1.09
Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study. Int J Obes (Lond) (2010) 1.09
Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med (1988) 1.08
Iodide symporter gene expression in human thyroid tumors. J Clin Endocrinol Metab (1998) 1.08
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults. Eur Respir J (2007) 1.08
Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC. Oncogene (1991) 1.07
An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway. Mol Cell Biol (1994) 1.07
Walking there: environmental influence on walking-distance estimation. Behav Brain Res (2011) 1.07
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. Oncogene (2006) 1.07
Thymosin beta-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro. Cancer Res (1998) 1.07
The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A). Oncogene (1989) 1.07
Analysis of the myeloproliferative sarcoma virus genome: limited changes in the prototype lead to altered target cell specificity. J Virol (1981) 1.07
FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential. Cell Death Dis (2013) 1.06
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival. Cancer Res (2000) 1.06
Retracted High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. Cell Death Differ (2005) 1.06
Transformation of mononuclear phagocytes in vivo and malignant histiocytosis caused by a novel murine spleen focus-forming virus. Nature (1985) 1.06